Association between Apnea of Prematurity and Respiratory Distress Syndrome in Late Preterm Infants: An Observational Study

por Olivier, François, Nadeau, Sophie, Caouette, Georges, Piedboeuf, Bruno
Publicado 2016

Impact of the Withdrawal of Palivizumab Immunoprophylaxis on the Incidence of Respiratory Syncytial Virus (RSV) Hospitalizations Among Infants Born at 33 to 35 Weeks’ Gestational A...

por Papenburg, Jesse, Defoy, Isabelle, Massé, Edith, Caouette, Georges, Lebel, Marc H
Publicado 2020

Human respiratory syncytial virus and other viral infections in infants receiving palivizumab

por Boivin, Guy, Caouette, Georges, Frenette, Line, Carbonneau, Julie, Ouakki, Manale, De Serres, Gaston
Publicado 2008

Cost-analysis of Withdrawing Immunoprophylaxis for Respiratory Syncytial Virus in Infants Born at 33–35 Weeks Gestational Age in Quebec: A Multicenter Retrospective Study

por Papenburg, Jesse, Saleem, Mahwesh, Teselink, Johannes, Li, Abby, Caouette, Georges, Massé, Édith, Lanctôt, Krista L.
Publicado 2020

Effects of maternal docosahexaenoic acid supplementation on brain development and neurodevelopmental outcomes of breastfed preterm neonates: protocol for a follow-up at preschool a...

por Guillot, Mireille, Robitaille, Carole-Anne, Turner, Laurence, Pronovost, Etienne, Caouette, Georges, Matte-Gagné, Célia, Olivier, François, Bartholomew, Julie, Massé, Édith, Morin, Alyssa, Mohamed, Ibrahim, Marc, Isabelle
Publicado 2022